High-Dose Atorvastatin Raises Threshold of Contrast-Induced Nephropathy in Diabetic Patients Undergoing Elective Coronary Intervention: A Randomized Controlled Study

Table 1

The baseline demographic, clinical, echocardiographic, and laboratory data of the studied population.

Parameter
Age in years (mean ± SD)	58.8 ± 7.8
Sex, males (%)	94 (47)
Smokers (%)	39 (19.5)
HTN (%)	77 (38.5)
Previous PCI (%)	8 (4)
Duration of DM in years (mean ± SD)	7 ± 3.9
Insulin therapy (%)	95 (47.5)
Heart failure (%)	44 (22)
Body mass index (mean ± SD)	27.2 ± 3.3
Heart rate in beats/min. (mean ± SD)	84.5 ± 14.5
Systolic blood pressure in mmHg (mean ± SD)	132.9 ± 18.8
Diastolic blood pressure in mmHg (mean ± SD)	83.9 ± 10.4
Segmental wall motion abnormalities (%)	68 (34)
EF (%) (mean ± SD)	59.3 ± 9.8
Volume of contrast in ml (mean ± SD)	121.4 ± 48.3
Time of X-ray exposure in min. (mean ± SD)	12 ± 5.5
Coronary procedure
PCI with one stent	133 (66.5)
PCI with two stents	53 (26.5)
PCI with more than two stents	14 (7)
TIMI flow
TIMI I	2 (1)
TIMI II	9 (4.5)
TIMI III	189 (94.5)
Baseline serum creatinine in umol/L (mean ± SD)	119.1 ± 16.8
Follow-up serum creatinine in umol/L (mean ± SD)	136.1 ± 25.6
Hemoglobin in mg/dL (mean ± SD)	12.3 ± 1.6
CIN (%)	24 (12)